{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:59:11Z","timestamp":1790362751223,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":83,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060485"],"award-info":[{"award-number":["82060485"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05529-5","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T14:03:29Z","timestamp":1783173809000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["High RSPO3 protein expression serves as an independent poor prognostic factor and promotes malignant progression in breast cancer"],"prefix":"10.1007","volume":"17","author":[{"given":"Shuyun","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanwei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,4]]},"reference":[{"key":"5529_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2021;71:209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA A Cancer J Clin"},{"key":"5529_CR2","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/cac2.12358","volume":"42","author":"R Hong","year":"2022","unstructured":"Hong R, Xu B. Breast cancer: an up-to-date review and future perspectives. Cancer Commun. 2022;42:913\u201336. https:\/\/doi.org\/10.1002\/cac2.12358.","journal-title":"Cancer Commun"},{"key":"5529_CR3","doi-asserted-by":"publisher","first-page":"721","DOI":"10.2147\/BCTT.S432526","volume":"15","author":"J Wang","year":"2023","unstructured":"Wang J, Wu S-G. Breast cancer: an overview of current therapeutic strategies, challenge, and perspectives. BCTT. 2023;15:721\u201330. https:\/\/doi.org\/10.2147\/BCTT.S432526.","journal-title":"BCTT"},{"key":"5529_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","volume":"10","author":"X Xiong","year":"2025","unstructured":"Xiong X, Zheng L-W, Ding Y, Chen Y-F, Cai Y-W, Wang L-P, et al. Breast cancer: pathogenesis and treatments. Sig Transduct Target Ther. 2025;10:49. https:\/\/doi.org\/10.1038\/s41392-024-02108-4.","journal-title":"Sig Transduct Target Ther"},{"key":"5529_CR5","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2174\/0113892029305656240503045154","volume":"25","author":"MS Hussain","year":"2024","unstructured":"Hussain MS, Agrawal M, Shaikh NK, Saraswat N, Bahl G, Bhat MM, et al. Beyond the genome: deciphering the role of MALAT1 in breast cancer progression. Curr Genomics. 2024;25:343\u201357. https:\/\/doi.org\/10.2174\/0113892029305656240503045154.","journal-title":"Curr Genomics"},{"key":"5529_CR6","doi-asserted-by":"publisher","DOI":"10.2174\/0118761429263841230926014118","volume":"17","author":"Y Naeimzadeh","year":"2023","unstructured":"Naeimzadeh Y, Heidari Z, Razban V, Khajeh S. Deregulated microRNAs involved in P53 signaling pathway in breast cancer with focus on triple-negative breast cancer. CMP. 2023;17:e18761429263841. https:\/\/doi.org\/10.2174\/0118761429263841230926014118.","journal-title":"CMP"},{"key":"5529_CR7","doi-asserted-by":"publisher","first-page":"681","DOI":"10.2174\/0109298665322427240906060626","volume":"31","author":"V Torun","year":"2024","unstructured":"Torun V, Degerli E, Cansaran-Duman D. Revealing the molecular signatures of miR-185-5p on breast cancer cells using proteomic analysis. PPL. 2024;31:681\u201395. https:\/\/doi.org\/10.2174\/0109298665322427240906060626.","journal-title":"PPL"},{"key":"5529_CR8","doi-asserted-by":"publisher","first-page":"72","DOI":"10.2174\/0115665232283880240301035621","volume":"25","author":"M Araghi","year":"2025","unstructured":"Araghi M, Gharebakhshi F, Faramarzi F, Mafi A, Mousavi T, Alimohammadi M, et al. Efficacy and safety of pembrolizumab monotherapy or combined therapy in patients with metastatic triple-negative breast cancer: a systematic review and meta-analysis of randomized controlled trials. Curr Gene Ther. 2025;25:72\u201388. https:\/\/doi.org\/10.2174\/0115665232283880240301035621.","journal-title":"Curr Gene Ther"},{"key":"5529_CR9","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2340\/1651-226X.2024.33008","volume":"63","author":"M Otterlei Fj\u00f8rtoft","year":"2024","unstructured":"Otterlei Fj\u00f8rtoft M, Huse K, Rye IH. The tumor immune microenvironment in breast cancer progression. AO. 2024;63:359\u201367. https:\/\/doi.org\/10.2340\/1651-226X.2024.33008.","journal-title":"AO"},{"key":"5529_CR10","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/s41556-022-01002-x","volume":"24","author":"K-C Kao","year":"2022","unstructured":"Kao K-C, Vilbois S, Tsai C-H, Ho P-C. Metabolic communication in the tumour\u2013immune microenvironment. Nat Cell Biol. 2022;24:1574\u201383. https:\/\/doi.org\/10.1038\/s41556-022-01002-x.","journal-title":"Nat Cell Biol"},{"key":"5529_CR11","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16:582\u201398. https:\/\/doi.org\/10.1038\/nrc.2016.73.","journal-title":"Nat Rev Cancer"},{"key":"5529_CR12","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1038\/s41388-021-02059-y","volume":"40","author":"EJ Ter Steege","year":"2021","unstructured":"Ter Steege EJ, Bakker ERM. The role of R-spondin proteins in cancer biology. Oncogene. 2021;40:6469\u201378. https:\/\/doi.org\/10.1038\/s41388-021-02059-y.","journal-title":"Oncogene"},{"key":"5529_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.placenta.2025.12.002","volume":"174","author":"A Edinger","year":"2026","unstructured":"Edinger A, Mohr CC, Elfroth EM, Walkenfort B, Voortmann S, Kimmig R, et al. Lymphatic mimicry of spiral arteries is impaired by human sFLT1 overexpression in a preeclampsia mouse model. Placenta. 2026;174:53\u201362. https:\/\/doi.org\/10.1016\/j.placenta.2025.12.002.","journal-title":"Placenta"},{"key":"5529_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4161\/cc.5.1.2305","volume":"5","author":"K-A Kim","year":"2006","unstructured":"Kim K-A, Zhao J, Andarmani S, Kakitani M, Oshima T, Binnerts ME, et al. R-spondin proteins: a novel link to beta;-catenin activation. Cell Cycle. 2006;5:23\u20136. https:\/\/doi.org\/10.4161\/cc.5.1.2305.","journal-title":"Cell Cycle"},{"key":"5529_CR15","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.33126","volume":"7","author":"AM Lebensohn","year":"2018","unstructured":"Lebensohn AM, Rohatgi R. R-spondins can potentiate WNT signaling without LGRs. Elife. 2018;7:e33126. https:\/\/doi.org\/10.7554\/eLife.33126.","journal-title":"Elife"},{"key":"5529_CR16","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1080\/07853890.2023.2166981","volume":"55","author":"Z He","year":"2023","unstructured":"He Z, Zhang J, Ma J, Zhao L, Jin X, Li H. R-spondin family biology and emerging linkages to cancer. Ann Med. 2023;55:428\u201346. https:\/\/doi.org\/10.1080\/07853890.2023.2166981.","journal-title":"Ann Med"},{"key":"5529_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-024-00521-6","volume":"13","author":"A Sharma","year":"2024","unstructured":"Sharma A, Debik J, Naume B, Ohnstad HO, Oslo Breast Cancer Consortium (OSBREAC), Sahlber KK, et al. Comprehensive multi-omics analysis of breast cancer reveals distinct long-term prognostic subtypes. Oncogenesis. 2024;13:22. https:\/\/doi.org\/10.1038\/s41389-024-00521-6.","journal-title":"Oncogenesis"},{"key":"5529_CR18","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1158\/1078-0432.CCR-21-3018","volume":"28","author":"A Seeber","year":"2022","unstructured":"Seeber A, Battaglin F, Zimmer K, Kocher F, Baca Y, Xiu J, et al. Comprehensive analysis of R-spondin fusions and RNF43 mutations implicate novel therapeutic options in colorectal cancer. Clin Cancer Res. 2022;28:1863\u201370. https:\/\/doi.org\/10.1158\/1078-0432.CCR-21-3018.","journal-title":"Clin Cancer Res"},{"key":"5529_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15704-y","volume":"7","author":"MM Fischer","year":"2017","unstructured":"Fischer MM, Yeung VP, Cattaruzza F, Hussein R, Yen W-C, Murriel C, et al. RSPO3 antagonism inhibits growth and tumorigenicity in colorectal tumors harboring common Wnt pathway mutations. Sci Rep. 2017;7:15270. https:\/\/doi.org\/10.1038\/s41598-017-15704-y.","journal-title":"Sci Rep"},{"key":"5529_CR20","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1093\/carcin\/bgy140","volume":"40","author":"Z Chen","year":"2019","unstructured":"Chen Z, Zhou L, Chen L, Xiong M, Kazobinka G, Pang Z, et al. RSPO3 promotes the aggressiveness of bladder cancer via Wnt\/\u03b2-catenin and Hedgehog signaling pathways. Carcinogenesis. 2019;40:360\u20139. https:\/\/doi.org\/10.1093\/carcin\/bgy140.","journal-title":"Carcinogenesis"},{"key":"5529_CR21","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2019.10778","author":"L Wu","year":"2019","unstructured":"Wu L, Zhang W, Qian J, Wu J, Jiang L, Ling C. R-spondin family members as novel biomarkers and prognostic factors in lung cancer. Oncol Lett. 2019. https:\/\/doi.org\/10.3892\/ol.2019.10778.","journal-title":"Oncol Lett"},{"key":"5529_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12935-016-0366-6","volume":"16","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, He R, Dang Y, Zhang X, Wang X, Huang S, et al. Comprehensive analysis of the long noncoding RNA HOXA11-AS gene interaction regulatory network in NSCLC cells. Cancer Cell Int. 2016;16:89. https:\/\/doi.org\/10.1186\/s12935-016-0366-6.","journal-title":"Cancer Cell Int"},{"key":"5529_CR23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41467-023-35795-8","volume":"14","author":"JM Lee","year":"2023","unstructured":"Lee JM, Hammar\u00e9n HM, Savitski MM, Baek SH. Control of protein stability by post-translational modifications. Nat Commun. 2023;14:201. https:\/\/doi.org\/10.1038\/s41467-023-35795-8.","journal-title":"Nat Commun"},{"key":"5529_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/978-1-4939-3578-9_6","volume-title":"Statistical genomics","author":"Z Wang","year":"2016","unstructured":"Wang Z, Jensen MA, Zenklusen JC. A practical guide to The Cancer Genome Atlas (TCGA). In: Math\u00e9 E, Davis S, editors. Statistical genomics. New York: Springer New York; 2016. p. 111\u201341."},{"key":"5529_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1398922","volume":"14","author":"J Zheng","year":"2024","unstructured":"Zheng J, Zeng B, Huang B, Wu M, Xiao L, Li J. A nomogram with Nottingham prognostic index for predicting locoregional recurrence in breast cancer patients. Front Oncol. 2024;14:1398922. https:\/\/doi.org\/10.3389\/fonc.2024.1398922.","journal-title":"Front Oncol"},{"key":"5529_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13058-021-01393-z","volume":"23","author":"ALV Johansson","year":"2021","unstructured":"Johansson ALV, Trewin CB, Fredriksson I, Reinertsen KV, Russnes H, Ursin G. In modern times, how important are breast cancer stage, grade and receptor subtype for survival: a population-based cohort study. Breast Cancer Res. 2021;23:17. https:\/\/doi.org\/10.1186\/s13058-021-01393-z.","journal-title":"Breast Cancer Res"},{"key":"5529_CR27","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/path.5999","volume":"258","author":"EJ Ter Steege","year":"2022","unstructured":"Ter Steege EJ, Boer M, Timmer NC, Ammerlaan CM, Song J, Derksen PW, et al. R\u2010spondin\u20103 is an oncogenic driver of poorly differentiated invasive breast cancer. J Pathol. 2022;258:289\u201399. https:\/\/doi.org\/10.1002\/path.5999.","journal-title":"J Pathol"},{"key":"5529_CR28","doi-asserted-by":"publisher","first-page":"4497","DOI":"10.1158\/0008-5472.CAN-17-2676","volume":"78","author":"JM Tocci","year":"2018","unstructured":"Tocci JM, Felcher CM, Garc\u00eda Sol\u00e1 ME, Goddio MV, Zimberlin MN, Rubinstein N, et al. R-spondin3 is associated with basal-progenitor behavior in normal and tumor mammary cells. Cancer Res. 2018;78:4497\u2013511. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-2676.","journal-title":"Cancer Res"},{"key":"5529_CR29","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1158\/0008-5472.CAN-22-1427","volume":"82","author":"E Timperi","year":"2022","unstructured":"Timperi E, Gueguen P, Molgora M, Magagna I, Kieffer Y, Lopez-Lastra S, et al. Lipid-associated macrophages are induced by cancer-associated fibroblasts and mediate immune suppression in breast cancer. Cancer Res. 2022;82:3291\u2013306. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-1427.","journal-title":"Cancer Res"},{"key":"5529_CR30","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ccell.2018.01.011","volume":"33","author":"A Costa","year":"2018","unstructured":"Costa A, Kieffer Y, Scholer-Dahirel A, Pelon F, Bourachot B, Cardon M, et al. Fibroblast heterogeneity and immunosuppressive environment in human breast cancer. Cancer Cell. 2018;33:463-479.e10. https:\/\/doi.org\/10.1016\/j.ccell.2018.01.011.","journal-title":"Cancer Cell"},{"key":"5529_CR31","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12943-020-01276-5","volume":"19","author":"X Xu","year":"2020","unstructured":"Xu X, Zhang M, Xu F, Jiang S. Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities. Mol Cancer. 2020;19:165. https:\/\/doi.org\/10.1186\/s12943-020-01276-5.","journal-title":"Mol Cancer"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05529-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05529-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05529-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:02:01Z","timestamp":1790359321000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05529-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,4]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5529"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05529-5","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,4]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The overall research was approved by the Ethics Committee of The Affiliated Hospital of Qinghai University and adheres to the Declaration of Helsinki. Written informed consent was obtained from all participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1377"}}